Visceral adiposity is associated with altered myocardial glucose uptake measured by 18FDG-PET in 346 subjects with normal glucose tolerance, prediabetes, and type 2 diabetes-Reference-Cited by-同舟云学术

Visceral adiposity is associated with altered myocardial glucose uptake measured by 18FDG-PET in 346 subjects with normal glucose tolerance, prediabetes, and type 2 diabetes

Published:2015-11-04 Issue:1 Volume:14 Page:
ISSN:1475-2840
Container-title:Cardiovascular Diabetology
language:en
Short-container-title:Cardiovasc Diabetol

Author:

Kim Gyuri,Jo Kwanhyeong,Kim Kwang Joon,Lee Yong-ho,Han Eugene,Yoon Hye-jin,Wang Hye Jin,Kang Eun Seok,Yun Mijin

Funder

Yonsei University College of Medicine

the National Research Foundation of Korea Grant funded by the Korean government

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,Endocrinology, Diabetes and Metabolism

Link

http://link.springer.com/content/pdf/10.1186/s12933-015-0310-4

Reference51 articles.

1. DeFronzo RA. Pathogenesis of type 2 diabetes mellitus. Med Clin North Am. 2004;88(4):787–835, ix.

2. Neeland IJ, Turer AT, Ayers CR, Powell-Wiley TM, Vega GL, Farzaneh-Far R, et al. Dysfunctional adiposity and the risk of prediabetes and type 2 diabetes in obese adults. JAMA. 2012;308(11):1150–9.

3. Nolan CJ, Damm P, Prentki M. Type 2 diabetes across generations: from pathophysiology to prevention and management. Lancet. 2011;378(9786):169–81.

4. van den Brom CE, Bulte CS, Loer SA, Bouwman RA, Boer C. Diabetes, perioperative ischaemia and volatile anaesthetics: consequences of derangements in myocardial substrate metabolism. Cardiovasc Diabetol. 2013;12:42.

5. Carley AN, Severson DL. Fatty acid metabolism is enhanced in type 2 diabetic hearts. Biochim Biophys Acta. 2005;1734(2):112–26.

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Subcutaneous adipose tissue radiodensity: An emerging risk factor for severe COVID-19;Nutrition;2024-12

2. Sex-specific differences in myocardial glucose metabolic rate in non-diabetic, pre-diabetic and type 2 diabetic subjects;Cardiovascular Diabetology;2024-04-26

3. Point‐of‐care β‐hydroxybutyrate measurement predicts adequate glucose metabolism suppression in cardiac FDG‐PET/CT;Clinical Physiology and Functional Imaging;2024-04-08

4. Relationship between body regional fat and cardiovascular disease in middle-aged and young adults: Results from NHANES 2011–2018 and Mendelian randomization meta-analysis;2024-03-20

5. Imaging diabetic cardiomyopathy in a type 1 diabetic rat model using 18F-FEPPA PET;Nuclear Medicine and Biology;2024-01